Obstetric Medicine 1 - Medical disorders in pregnancy Flashcards

1
Q

What are overall physiological changes in pregnancy?

A
Increased Plasma Volume
Increased Cardiac Output
Increased Stroke Volume
Increased Heart Rate
Increased DBP/SBP
Decreased TPVR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are changes in renal physiology in pregnancy?

A

Effective renal plasma flow and glomerular filtration rate increase from ~10/40

70% increase in renal blood flow, plethoric kidney swells
Increased bipolar diameter 1cm
Increased GFR (50%)
Proteinuria increases (L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the definition of hypertension in pregnancy?

A

Systolic >140 or diastolic >90 on >=3 readings
Severe >160/110
High risk of maternal morbidity and mortality, need for immediate treatment

Normal BP in preg - 111.5/65.2 at 12/40
115/69 by 37/40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are classification of hypertension in pregnancy?

A
Preeclampsia-eclampsia 41%
Gestational HTN (36%) - after 20/40
Chronic HTN
 - essential 15%
 - 2ndary 5%
 - white coat
Pre-eclampsia + chronic HTN 3%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What was the outcome of the CHIPS study wrt HTN control in prengnacy?

A

Pts with non-proteinuric gestational or pre-gestational HTN
Compared tight and less tight BP control (DBP160/110)

Found that metyldopa was superior to labetalol in primary outcome, BP control and PET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are appropriate antihypertensive medications in pregnancy?

A

Methyl dopa - central
Clonidine - central
Labetalol - b-blocker, mild alpha vasodilator
Oxprenalol - b-blocker with sympathomimetic activity
NIfedipine - Ca channel blocker
Prazosin - alpha blocker
Hydralazine - vasodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the effect of pregnancy on the metabolism of certain antihypertensive medications?

A

Increased CYP2D6 metabolism of metoprolol, propranolol and clonidine
Increased CYP3A4 metabolism of nifedipine and amlodipine
Increased conjugation to glucoronide of B-isomer of labetalol

these changes may require increase in dosing frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are recommended treatment options for severe, sustained HTN in pregnancy (acute lowering of BP)?

A

Labetalol - 20-80mg, IV bolus over 2 minutes, repeat every 10 minutes
Nifedipine - 10-20mg tablet, max 40mg
Hydralazine IV bolus
Diazoxide - IV rapid bolus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are features of proteinuria in pregnancy?

A

Important sign of underlying renal disease
Useful in the Dx of PET - proteinuria presence should determine management - level of proteinuria less critical (not a marker of severity of PET)

Proteinuria does increase in pregnancy - 300mg/24hrs ULN, spot prot:creat ratio 0.03 g/mmol

There is increased permeability in the GBM in the 3rd trimester, proteinuria at baseline doubles in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are epidemiological features of pre-eclampsia?

A

5% of pregnancies
worldwide 50k maternal deaths/year
cured by delivery
30% of cases occur post partum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the definition of pre-eclampsia?

A
New onset HTN >20/40, accompanied by >=1 of:
renal involvement
 - proteinuria >0.03g/mmol
 - raised creatinine >90umol/L
 - oliguria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is pathogenesis of PET?

A

1) Genetic factors, abnormal trophoblast/decidual interaction, oxidative stress and increased AT1 autoantibodies
2) failure of physiological transformation of myometrial segment of spiral artery - defective deep placentation - placental dysfunction
3) oxidative and endoplasmic reticulum stress, proinflammatory CKs, increased AT1 autoantibodies, syncitiotrophoblast microparticles and nanoparticles
4) leads to increase in antiangiogenesis (sVEGFR-1, sEndoglin) and decreasd angiogenesis (PIGF, VEGF)
5) leucocyte and endothelial cell activation and end organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are biomarkers implicated in PET?

A

VEGF/PLGF
Increased levels of SFLT1 and sENG are implicated in failed interaction of TGF-B1 and VEGF with ALK5, TBRII and ENG and FLT1

sFlt-1:PlGF ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are risk factors for PET?

A
nulliparous women
35yo
Hx of PET in prev pregnancy
Multi-foetal gestation
Obesity
FHX of PET
Pre-existing chronic HTN, DM, APL, Thrombophilia, AID, renal dz, infertility
Limited sperm exposure
Urinary Tract infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment of PET?

A
delivery if >34 weeks
Expectant if safe to do so
High risk signs:
- uncontrolled severe HTN
- HELLP
- renal dysfunction
- eclampsia
- severe IUGR
- pulmonary oedema
Prevent eclampsia with MgSO4 (NNT=300 overall, much lower in high risk patients)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are preventative measures for PET?

A

Aspirin daily 12% decrease in risk, stillbirth and IUGR - greatest benefit in highest risk

L-arginine and Vit C/E promisin
Ca supplementation in Ca deficiency

New and exciting

  • pravastatin increase angiogenic factors, andioxidant and anti-inflammatory
  • Plasmapharesis - removal of sFLT1 and sEndoglin
  • VEGF
  • PPIs - upregulate haemoxygenase
  • sleep apnoea and CPAP
  • Melatonin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are long-term sequelae of PET?

A
higher risk of CVD
HTN OR 3.13
CVD OR 2.29
CVA 1.76
ESRF 4.70
Diabetes 1.8

higher risk of metabolic syndrome in growth restricted infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are pre-pregnancy issues in patients with CKD?

A
control BP
 - switch to methyldopa, labetalol, nifedipine
 - stop ACE/ARB - malformations at all trimesters
 - alter immunosuppression
 - assess baseline proteinuria
in pregnancy
 - BP control
 - aspirin and calcium
 - anticoagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the relationship between foetal outcomes and renal function?

A

Significantly worsened rates of SGA, permature delivery and NICU in patients with worsening renal function (TOCOS study)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the pattern of renal deterioration during CKD pregnancies?

A

In pts with creat >180 at conception

  • 50% stable
  • 30% decline during pregnancy and after
  • 8% worse during pregnancy and recover 6/12 post partum
  • 10% decline 6/52 to 6/12 post partum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the relationship between stage I CKD and outcomes

A

Outcomes have been shown to be poor in women with only mild CKD (stage I)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When should A/C be considered in patients with CKD and pregnancy?

A

When albumin 3gm/protein/24 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the benefit of nocturnal haemodialysis in pregnancy?

A

Increases time of dialysis - in pts receving >36 hrs dialysis vs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are relative outcomes of pregnancy in renal transplant patients?

A

88% live births, 10% spontaneous abortions, 2% stillbirths

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are conditions of pregnancy post transplant?

A

Generally >1year post transplant
Stable renal function
Off teratogenic medications
Infective risk low (CMV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are teratogenic immunosuppressive agents in pregnancy?

A

cyclosporin, tacrolimus, steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What immunosuppressant agents are safe in pregnancy?

A

Calcineurin inhibitors - cyclosporin, tacrolimus
- no increase in malformations
- no LT learning or behavioural difficulties
- HTN and DM issues
Azathioprine safe
- crosses placenta
- foetus lacks enzyme to convert to 6 mercaptopurine

STOP ACE AND ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are different issues with liver and renal transplant pregnancies?

A

Liver transplant pregnancies more likely to be successful
Higher rates of rejection post partum in liver transplants.

Higher rates of unsuccessful pregnancies in renal transplants, in addition to PET, IUGR, early delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What immunomodulatory agents are safe in breast feeding?

A

azathioprin, tacrolimus, cyclosporin expressed at low levels in breast milk ?ok

NO lt f/u studies at present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the relationship between immunity and pregnancy?

A

may act as a sensitising agent
50% of women have HLA Ab post pregnancy
should avoid blood transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are significant issues with SLE and pregnancy?

A

Active lpus
Lupus nephritis - HTN, renal impairment
Ro and La Ab - CHB
Antiphospholipid syndrome - clots

Can cause

  • increased lupus activity
  • pre-eclampsia
  • IUGR
  • early delivery
  • foetal death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are prognostic signs in lupus nephritis and pregnancy?

A

outcomes are worse even in quiescent disease

Poor prognostic signs:

  • hypertension
  • high creatinine
  • proteinuria >1g
  • active disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are outcomes in SLE and pregnancy?

A

Unsuccessful pregnancy 23%

Premature birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are methods of differentiating between PET and SLE renal flare?

A
Casts/RBCs absent in urine in PET
No involvement of skin or joints in lupus
Urate generally elevated in PET
LFTs rarely deranged in SLE
C3 and C4 low in lupus
Andi-dsDNA elevated in lupus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are features of Ro/La Ab in SLE and pregnancy?

A

30% of lupus population
Assoc with photosensitivity, raynauds, sjogrens

Causes CHB 2% in children, neonatal lupus in 5% (no sequalae with neonatal lupus)

36
Q

What are clinical features of ApL

A

Thrombosis - arterial or venous
Pregnancy related:
- 3 consec miscarriages with nil chromosomal abn or other maternal cause)
- neonatal death after 10 weeks due to placental insufficiency
- delivery

37
Q

What are laboratory features of ApL?

A

aCL IgG and or IgM at high titre, >=2 occasions, 12/52 apart
LA +Ve >=2 occasions, 12/52 apart
anti-B2-GP Ab >99th centile, >=2 occasions, 12/52 apart

38
Q

What is the management of ApL in pregnancy?

A

In pts who are preg and have lab evidence only, LD-ASA
In patients with ApL and venous/art thrombosis - LMWH and aspirin
APL with foetal loss, PET or IUGR - LMWH 40mg and aspirin
in pts with APL and recurrent foetal loss - ASA pre preg, LMWH with ASA intraparutm, add steroids if loss whilst on ASA and clexane

39
Q

What SLE medications are OK in pregnancy/lactation?

A
NSAIDS (avoid after 32/40)
plaquenil
corticsteroids
cyclosporine/tacrolimus
Azathoprine

Heparin
ASA

40
Q

What SLE medications are C/I in pregnancy?

A

MMF (also not in BF)
MTX (also not in BF)
Cyclophosphamide (also not in BF)
Warfarin (ok in BF)

41
Q

What is the utility of hydroxychloroquine in pregnancy?

A

decreases incidence of flares, including renal flares
safe in pregnancy/lact
improves hypoglycaemia, lowers lipids, protect OP
anti-thrombotic effects
? role in reducing cardiomyopathy in CHB and Ro positive

42
Q

What is the safety of biological agents in pregnancy?

A

no increase in adverse outcomes
no increase in congenital malformations
no increase in RR of infections in 1st life
avoid live vaccines in 1st year of life

43
Q

What are maternal respiratory changes?

A

Increase in alveolar ventilation
Increase in minute ventilation
Increase in tidal volume
Mild increase in resp rate, plateaus at 20 weeks

pH increases, PaO2 increases then falls to level below peak, but above baseline, PaCO2 drops (30)

44
Q

What are common respiratory Sx in pregnancy?

A
Dyspnoea common (70%), in T2-3
talking and sitting issues, reduced exercise tolerance
45
Q

What are features of asthma in pregnancy?

A

12% pregnant women have asthma
1/3 stable, 1/3 improve, 1/3 worsen
poor control leads to PET, IUGR and early delivery
Budesonide is class A
oral C/S when indicated
Symbicort/seretide if moderate/severe asthma

46
Q

What are features of thromboembolism in pregnancy?

A

Increased risk in pregnancy
Increases procoagulant factors, decreases inhibitors
1-2/1000 pregnancies, with 5x antepartum risk
Higher risk post-partum (10-20x)
DVTs are more common antepartum, equal risk T1-T2, most risk 1st 6 weeks postpartum.
70% left sided, ileofemoral, post phebitic syndrome

PE most risk post-partum

47
Q

When is prophylactic A/C indicated antepartum?

A
High risk of thrombosis:
- Past Hx of unprovoked DVT/PE
- Past Hx provoked DVT/PE i.e OCP
- past hx DVT/PE ante/post partum
- High risk thrombophilia with +ve FHx
 (homo FVL, Homo PT gene mutation)
APLS, poor obstetric Hx

Prevention post partu:

  • Higher risk ++
  • all of the above
  • high risk thrombophilia with nil FHx
  • past Hx DVT (provoked or unprovoked)
  • risk factor profile
48
Q

When is full dose AC indicated antepartum?

A

warfarin pre-pregnancy
recurrent clots - thrombophilia w clots, APLS, prosthetic valves

Use LMWH, as warfarin teratogenic (high risk HVs)

crosses placenta - hare lip, bone abnormalities, foetal haemorrhage

safe postpartum

49
Q

What are highest risk factors for Pregnancy associated VTE?

A

Immobility OR 10.1
Active medical illness 8.7
Pre-eclampsia 5.8

Other important factors Age >35, obesity (OR 5.3), smoking
Varicose veins, planned casesarian section

If >3 RFs - recommend prophylaxis

50
Q

What are highest risk thrombophilias for PA-VTE?

A
AT deficiency (in pts w FHx) - 18%
FVL homozygous w FHx- 17%

Also FVL/prothrombon mut compount hetero, protein C, protein S deficiency

51
Q

What are Dx methods in PA-VTE/PE?

A

D-dimer - no std ref ranges, not recommended

DVT - comp USS - Sn 97, Sp 94 (72% are ileofemoral in pregnancy) - If -ve and clinical suspicion, anticoagulate and repeat doppler 1 week (can consider MRI direct thrombus imaging, or venography)

For PE - CXR then V/Q scan - Normal NPV 99%, high prob PPV >85%

Low prob VQ and high clin suspicion - negative doppler, can CTPA (10% inc breast ca) or anticoagulate and repeat test in 1 week

52
Q

What are examples of pregnancy specific liver disorders?

A

Hyperemesis
HELLP/PET
Intrahepatic cholestasis
AFLP

53
Q

What are general changes in LFTs in pregnancy?

A

decreased albumin and increased ALP

54
Q

What are features of hyperemesis gravidarum?

A

0.3-2% of pregnancies
NV, wt loss >5%, fluid and electrolyte disturbances
1st trimester
50-60% have liver involvement - ALT 2-5 x, usually Bile acids and bili normal
RFs - inc BMI, DM, multiple pregnancies, molar pregnancies, hyperthyroidism

55
Q

What are features of HELLP (atypical presentation of PET)

A

Thrombocytopenia, elevated liver enzymes (200-2000 ALT, AST), haemolysis (Intravascular) - LDH >600

70% antepartum, 3rd trimester, 30% post
S+Sx - NV, RUQ discomfort 80%, tenderness, PET in 70% of cases.

56
Q

What is the pathology of HELLP?

A

endothelial activation
platelet aggregation
fibrin deposition in sinusoids, necrosis and haemorrhage

57
Q

What are complications and treatment of HELLP?

A

Complications - liver infarction, haematoma (fever, LDH >2000), fetal abruption, prematurity, death

Treat with delivery and MG

Recurrence in 30-40%

58
Q

What are features of acute fatty liver of pregnancy?

A

Mat mortality 1.4%
Perinatal mortality 104/100,000
3rd trimester

More common if:
1st and multiple pregnancy
male foetus
low BMI (20%)
disorders of fatty acid metabolism (LCHAD) heterozygous mum and heterozygous fetus
(FA major source of energy for foetus)
59
Q

What are featuers of fatty acid oxidation disorders?

A

AR
LCHAD most common - short and medium chains
FAO dis increase incidence of maternal liver disease
Long chain disorders x50 risk of maternal liver disease
- 79% change of AFLD or HELLP
- increase incidence of cholestasis and hyperemesis
x12 time risk with short and medium chain dz
Follow-up LFTs, glucose
Screen FAO disorders - carnitine (free and total), acylcarnitine profile

60
Q

What is Dx criteria for AFLP?

A
>=6 of:
vomiting
abdo pain
polydipsia/polyuria
encephalopathy
high bili
hypoglycaemia
high uric acid
leucocytosis
ascites/bright liver on USS
HIgh AST/ALT
high ammonia
renal impairment
coagulopathy
microvesicular steatosis on liver Bx
61
Q

What are Bx findings in AFLP?

A

hepatocytes have clear cytoplasm or many vacuoles consistent with steatosis’
features consistent with steatohepatitis

62
Q

What is Mx of AFLP?

A
multidisciplinary team
early delivery once stable
correct coagulopathy/hypoglycaemia
NAC/?PLEX
preparation for transplanation
20% recurrence in future pregnancies
no long term liver disease
screen infants for hypoglycaemia
consider genetic testing
63
Q

What are features of intrahepatic cholestasis of pregnancy?

A
2nd 1/2 or T3 of preg, normal post
itch palms and soles
increase in bile acids >10 (Fasting)
abnormal AST >20ULN
GGT and bili normal
jaundice not common (10-15%)
benign - mostly resolves post partum
higher risk of cholecystitis, cirrhosis, pancreatitis and AI hepatitis
cholestasis with oral contraceptives
recurrence in future pregnancies
64
Q

What is the pathophysiology of intrahepatic cholestasis of pregnancy?

A

Genetic susceptibility (scandinavians and sth americans)
15% have MDR3 mutation
FA ox disorders
higher risk hep C, twins, age >35
role of sulphated progesterone metabolites

65
Q

What are foetal implications in intrahepatic cholestasis of pregnancy?

A
increased risk of:
- premature delivery
- meconium liquor
- resp distress
- still birth
>40 BA level = increased risk
bile acids are toxic
66
Q

What is treatment of intrahepatic cholestasis of pregnancy?

A

topical menthol, avoid heat
ursodeoxycholic acid - decreases BA levels and progesteroene metabs - improves LFTs and is superior to cholestyramine, steroids

dex, cholestyramine, s adenosine methionine, rifampicin

67
Q

What is the utility of UDCA in ICP?

A

decreases pruritis, pre-term labour, meconium stained liquor, resp distress and NICU admissions, ? no change in stillbirth

68
Q

When is treatment with antivirals indicated in hep B +ve pregnancy?

A

> 10^6 means must treat with TDF to decrease viral load from 32/40 - 6-8 weeks post partum

69
Q

What is the rate of HCV infection (vertical)

A

only occurs in PCR +Ve women - negible if VL undet >10^7 = high risk
1/3 early in utero, 40-50% late in utero/delivery
>15% are infected at birth - 20% spontaneous resolution as per aduts.
5.8% is final rate (1/20)

no treatment per se - avoid invasive procedures

70
Q

What are cutoffs for procedures in thrombocytopenia?

A
>150 normal
>100 not uncommon, nil issues
>80 - epidurals, spinal
> 50 instrumented delivery
>20 - spont bleeding
71
Q

What are features of gestational thrombocytopenia?

A
5-6% of pregnancies
? dilution/immune/sequestration
90% have >100, can fall to 70
Dx of exclusion - normal counts T1-2, recurs with pregnancy, normalised post partum
no increase of thrombocytopenia in baby
72
Q

What are features of ITP in pregnancy?

A

common in age group
5% causes of thrombocytopenia in pregnancy
risk of IgG transmission to foetus
- thrombocytopenia/IC haemorrhage
maternal plt count doesnt predict foetal plt count
treatment pre delivery/with bleeding (aim >80)
- pred
- IVIg
- Imuran/splenectomy/rituximab

73
Q

What are normal haemodynamic changes in pregnancy?

A

BV increased 40-50% during pregnancy - autodiuresis post
Heart rate increases 10-15/min
CO increased 30-50% preg, extra 50% labor
BP decreased 10mmhg
SV inc in T1-2, dec in 3rd - increased in labor
SVR - decreased pregancny, increased labor

74
Q

What are risk IV conditions for pregnancy?

A

PAH of any cause
Severe LV dysfunction 45mm aorta
Aortic dilatation >50mm with bicuspid valve
native severe coarctation

75
Q

What are risk III conditions in pregnancy?

A
Mechanical valve
Systemic right ventricle
Fontan circulation
Cyanotic heart disease
Other complex congenital disease
Aortic dilatation 40-45mm Marfans, 45-50mm in aortic disease with bicuspid valve
76
Q

What are risk in mechanical heart valves in pregnancy?

A

greater risk of complications and mortality
balance risk of thrombosis vs bleeding
clexane 6-14 weeeks, warfarin if high risk of thrombosis
unfractionated heparin at delivery
aspirin
factor Xa monitoring

77
Q

What are outcomes of recent studies in GDM?

A

ACHOIS - treatment decreases risk of complications from 4% to 1%

HAPO - perinatal risks are increased even with normalised values

LANDON - treatment of mild GDM reduces risk of macrosomia, shoulder dystocia, PET and CS

78
Q

What are diagnostic criteria for GDM?

A

Fast venous PG >=5.1
1hr post venous >=10
2hr venous PG >=8.5

Any one of above

79
Q

What are recommendations for vaccination in pregnancy?

A

single dose of pertussis for all pregnant women in T3

influenza for all pregnant women

80
Q

What are features of thyroid disorders in pregnancy?

A
thyroid requirements incr by 30%
foetus produces endogenous T4 by 20 weeks
hCG stimulates TSHr
Hyperthyroidism/hypothyroidism
postpartum thyroiditis
81
Q

What happens to TSH in pregnancy?

A

TSH falls in T1 and increases during pregnancy (opposite of hCG)

82
Q

What are upper limits of TSH in pregnancy?

A

T1 - 2.5
T2 - 3
T3 - 3.5

83
Q

What are definitions of OH and SCH in pregnancy?

A

OH - TSH elevated to >2.5 or decreased FT4
TSH >=10 regardless of FT4

SCH - TSH between 2.5-10 with normal FT4

84
Q

What are requirements for iodine in pregnancy?

A

220ug/d pregnancy
290 ug/day lactation
need pregnancy mulitvitamins

85
Q

What are features of hypothyroidism in pregnancy?

A
overt hypothyroidism:
- impaired foetal cognitive and neuropsych development
- miscarriage, IUGR, PET
- treat to target TSH range
subclinical hypothyroidism
- miscarraige
- more controversial - ? premature delivery, neurocognitive deficits
-- treatment if TPO Ab positive
- overtreated at present
86
Q

What are features of thyrotoxicosis in pregnancy?

A

low TSH - High T3, T4

  • hyperemesis, mole
  • grave’s is commonest cause of thyrotoxicosis in reporductive years
  • if TSHr Ab positive - risk of neonatal thyrotoxicosis

Treatment - FT4 upper limit of normal

  • PTU 1st trimester (risk of fatal hepatotoxicity)
  • CBZ/MMI - 2nd and 3rd trimester, post partum
  • applasia cutis, choanal and oesophageal atresia.